X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (43) 43
animals (34) 34
neurosciences (33) 33
alzheimer's disease (28) 28
humans (27) 27
amyloid-induced neurotoxicity (22) 22
amyloid-induced neurodegeneration (20) 20
alzheimers-disease (19) 19
pharmacology & pharmacy (15) 15
oxidative stress (14) 14
amyloid-induced toxicity (13) 13
article (13) 13
biochemistry & molecular biology (12) 12
neurodegenerative diseases (11) 11
phosphorylation (11) 11
alzheimer disease - pathology (10) 10
neurodegeneration (10) 10
rats (10) 10
tau proteins - metabolism (10) 10
alzheimer disease - drug therapy (9) 9
cell biology (9) 9
glycogen-synthase kinase-3 (9) 9
glycogen-synthase kinase-3-beta (8) 8
hippocampal-neurons (8) 8
neurology (8) 8
neuroprotective agents - pharmacology (8) 8
review (8) 8
alzheimer disease - metabolism (7) 7
alzheimer’s disease (7) 7
blood-brain-barrier (7) 7
brain (7) 7
male (7) 7
mice (7) 7
neurons (7) 7
neurons - drug effects (7) 7
paired helical filaments (7) 7
proteins (7) 7
tau (7) 7
alzheimers disease (6) 6
analysis (6) 6
antioxidants (6) 6
bipolar disorder (6) 6
clinical neurology (6) 6
geriatrics & gerontology (6) 6
lithium (6) 6
neurons - pathology (6) 6
neuroprotection (6) 6
nf-kappa-b (6) 6
amyloid-induced dynamin-1 (5) 5
antioxidants - therapeutic use (5) 5
cells, cultured (5) 5
central-nervous-system (5) 5
glycogen synthase kinase 3 - metabolism (5) 5
in-vivo (5) 5
kinases (5) 5
life sciences (5) 5
mental disorders (5) 5
nervous system diseases (5) 5
neurite outgrowth (5) 5
neurodegenerative diseases - drug therapy (5) 5
neurons - metabolism (5) 5
neuroprotective agents - therapeutic use (5) 5
parkinsons-disease (5) 5
phosphorylation - drug effects (5) 5
psychiatry (5) 5
reactive oxygen species - metabolism (5) 5
signal transduction - drug effects (5) 5
antioxidants - pharmacology (4) 4
apoptosis (4) 4
apoptosis - drug effects (4) 4
beta (4) 4
biomedicine (4) 4
blood-brain barrier (4) 4
cell death (4) 4
cell survival - drug effects (4) 4
cell-death (4) 4
chemistry, medicinal (4) 4
disease models, animal (4) 4
drug therapy (4) 4
hippocampus (4) 4
inhibition (4) 4
lipids (4) 4
medical research (4) 4
medicine, botanic (4) 4
medicine, herbal (4) 4
neurodegenerative diseases - genetics (4) 4
neurodegenerative diseases - metabolism (4) 4
oxidative stress - drug effects (4) 4
pc12 cells (4) 4
pharmacology (4) 4
polyphenols (4) 4
protein-kinase-c (4) 4
rats, sprague-dawley (4) 4
research (4) 4
tau proteins - genetics (4) 4
therapeutics (4) 4
transgenic mice (4) 4
transgenic mouse model (4) 4
a-beta (3) 3
alzheimer disease - genetics (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Molecular Neurodegeneration, ISSN 1750-1326, 2009, Volume 4, Issue 1, pp. 13 - 13
Journal Article
NEUROSCIENCE, ISSN 0306-4522, 10/2017, Volume 362, pp. 104 - 117
The dysregulation of posttranslational modifications of the microtubule-associated protein (MAP) tau plays a key role in Alzheimer's disease (AD) and related... 
AMYLOID-INDUCED DYNAMIN-1 | MECHANISM | cytoskeleton | mitochondria | ALZHEIMERS-DISEASE | PROTEIN-TAU TAU | CLEAVAGE | NEUROSCIENCES | degeneration | BETA | MATURE HIPPOCAMPAL-NEURONS | IN-VIVO | axonal transport | FAST AXONAL-TRANSPORT | lysosomes | INDUCED NEUROTOXICITY
Journal Article
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 09/2010, Volume 30, Issue 36, pp. 11938 - 11950
Aggregation of amyloid-beta (A beta) and Tau protein are hallmarks of Alzheimer's disease (AD), and according to the A beta-cascade hypothesis, A beta is... 
AMYLOID-INDUCED NEURODEGENERATION | OXIDATIVE STRESS | PROTEIN OLIGOMERS | NEURITE OUTGROWTH | MECHANISM | ALZHEIMERS-DISEASE | AXONAL-TRANSPORT | PRECURSOR PROTEIN | NEUROTOXICITY | NEUROSCIENCES | CULTURED HIPPOCAMPAL-NEURONS
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2006, Volume 281, Issue 29, pp. 20315 - 20325
In this study, we investigated the molecular basis for the altered signal transduction associated with soluble amyloid beta-protein (A beta) oligomer-mediated... 
AMYLOID-INDUCED NEURODEGENERATION | HUMAN MONOCYTIC THP-1 | COGNITIVE DECLINE | ALZHEIMERS-DISEASE | PROTEIN-KINASE | MAP KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | IN-VIVO | NEURONS | LONG-TERM POTENTIATION | CELL-DEATH
Journal Article
RSC Advances, ISSN 2046-2069, 2016, Volume 6, Issue 27, pp. 22827 - 22838
A series of 4-O-substituted chrysotoxine (CTX) derivatives were designed, synthesized and evaluated as multifunctional agents for the treatment of Alzheimer's... 
THERAPEUTICS | DESIGN | AMYLOID-INDUCED NEUROTOXICITY | HYPOTHESIS | TAU | NEURODEGENERATION | BETA-AGGREGATION | INHIBITORS | PC12 CELLS | BLOOD-BRAIN-BARRIER | CHEMISTRY, MULTIDISCIPLINARY
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 2010, Volume 32, Issue 1, pp. 1 - 14
Journal Article
Journal Article
Neuropharmacology, ISSN 0028-3908, 09/2017, Volume 123, pp. 332 - 348
Prion diseases are a group of infectious neurodegenerative diseases characterized by multiple neuropathological hallmarks, including accumulation of PrP ,... 
Neuroprotection | Prion diseases | REST | Wnt signaling | Lithium treatment | NERVOUS-SYSTEM | STEM-CELLS | ALZHEIMERS-DISEASE | GLYCOGEN-SYNTHASE KINASE-3 | BETA-CATENIN | BIPOLAR DISORDER | HIPPOCAMPAL-NEURONS | NEUROSCIENCES | AMYLOID-INDUCED NEURODEGENERATION | PHARMACOLOGY & PHARMACY | HUNTINGTONS-DISEASE | PARKINSONS-DISEASE | Neurons - pathology | Peptide Fragments - toxicity | Oxidative Stress - physiology | Cerebral Cortex - pathology | Wnt Signaling Pathway - physiology | Synapses - pathology | Cerebral Cortex - metabolism | Cell Nucleus - metabolism | Neuroprotective Agents - pharmacology | Synapses - metabolism | Cell Nucleus - pathology | Lithium Chloride - pharmacology | Neurons - metabolism | Cell Death - drug effects | Cerebral Cortex - drug effects | Neurons - drug effects | Cell Survival - physiology | Repressor Proteins - metabolism | Cell Survival - drug effects | Synapses - drug effects | Prion Diseases - drug therapy | Cells, Cultured | Repressor Proteins - genetics | Glycogen Synthase Kinase 3 beta - antagonists & inhibitors | Prion Diseases - pathology | Glycogen Synthase Kinase 3 beta - metabolism | Rats, Sprague-Dawley | beta Catenin - metabolism | Prions - toxicity | Up-Regulation - drug effects | Animals | Wnt Signaling Pathway - drug effects | Cell Death - physiology | Oxidative Stress - drug effects | Cell Nucleus - drug effects | Prion Diseases - metabolism | Nervous system diseases | Synthesis | Peptides | Neurons | Glycogen | Cell death | Prions | Physiological aspects | Epidemiology | Zoonoses | Index Medicus
Journal Article
Journal Article
Journal Article